Knowstox

Fundamentals snapshot

Medical Properties Trust, Inc.

MPT · NYQ · Real Estate · REIT - Healthcare Facilities

Current price

$3.65

52-week range

$3.36 - $6.47

Market cap

$2.18B

One-glance verdict

Overvalued

$-7.14 our estimate vs market $3.65

Wall Street consensus: $5.12 (-171.8% lower than our fair-value estimate)

Balance sheet

Distressed

1.05x Concerning

Net debt $9.31B. Interest coverage shows how many times profit covers the interest bill.

What this company does

Medical Properties Trust, Inc.

Medical Properties Trust is a special type of company called a real estate investment trust (a company that owns buildings and rents them out), which focuses only on owning hospital properties. It makes money by buying hospital buildings and then leasing them back to the hospital operators, collecting steady rent payments. This business model allows hospitals to raise cash for improvements by selling their real estate, while providing the company with a reliable, long-term source of income.

Price history

How the share price has moved

Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Revenue $252.06M
Net income $32.83M
Diluted EPS 0.05
Operating cash flow $-14.26M
Free cash flow
Revenue $270.34M
Net income $17.31M
Diluted EPS 0.03
Operating cash flow $160.06M
Free cash flow
Revenue $237.52M
Net income $-77.73M
Diluted EPS -0.13
Operating cash flow $18.57M
Free cash flow
Revenue $240.36M
Net income $-98.36M
Diluted EPS -0.16
Operating cash flow $51.75M
Free cash flow
Revenue $223.80M
Net income $-118.28M
Diluted EPS -0.20
Operating cash flow $384.00K
Free cash flow
Revenue $231.84M
Net income $-412.85M
Diluted EPS -0.68
Operating cash flow $76.69M
Free cash flow
Revenue $225.83M
Net income $-801.16M
Diluted EPS -1.34
Operating cash flow $59.20M
Free cash flow
Revenue $266.56M
Net income $-320.63M
Diluted EPS -0.54
Operating cash flow $35.26M
Free cash flow

Is it cheap or expensive?

Fair value $-7.14 vs current price $3.65

Wall Street consensus is the average analyst price target: $5.12 (-171.8% lower than our fair-value estimate).

Our most-likely fair value is $-7.14 a share — about 295.6% below today's price of $3.65, so the stock currently looks expensive (overvalued).

overvalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 2.5% · Discount 10.1% · Terminal 2.5%

$-7.14

Bear

Growth 2.5% · Discount 10.1% · Terminal 2.5%

$-7.14

Bull

Growth 5.0% · Discount 10.1% · Terminal 2.5%

$-5.89

Is it drowning in debt?

Distressed

Net debt $9.3B. Interest coverage 1.1x.

Net debt $9.31B
Interest coverage 1.05x

Medical Properties Trust, Inc.'s profit covers its interest bill about 1.1 times over. which is stronger than most peers shown here and 2 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.

Distressed
Worse cushion Baseline Better cushion
MPT BASELINE Medical Properties Trust, Inc.

Total debt $9.70B Interest coverage 1.05x This is the baseline the peer rows are being compared against.

Total debt $4.03B Interest coverage 3.46x +229% vs MPT Carries about 3.3x more debt cushion than MPT.

Total debt $12.92B Interest coverage 1.40x +33% vs MPT Carries about 1.3x more debt cushion than MPT.

Total debt $19.72B Interest coverage 0.54x -48% vs MPT Carries about 1.9x less debt cushion than MPT.

Total debt $10.32B Interest coverage 1.78x +70% vs MPT Carries about 1.7x more debt cushion than MPT.

Total debt $4.40B Interest coverage 0.46x -56% vs MPT Carries about 2.3x less debt cushion than MPT.

What you should know

The case for and against MPT

3 Rewards 2 Risks

Rewards

  • Revenue grew 2.9% last year.
  • Free cash flow was positive in 4/10 years.
  • Dividend yield is 10.6% with 22-year payout history.

Risks

  • Operating margin compressed from 65.1% to 57.4% over 3 years.
  • Return on equity was -0.6% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
Forward P/E
73.00x
P/B
0.48x
P/S
1.97x
EV/EBITDA
11.95x
PEG ratio
1.61x

Profitability

How much profit each dollar creates

Gross margin
95.9%
Operating margin
57.4%
Net margin
-2.7%
ROE
-0.6%
ROA
2.8%

Health

Liquidity and balance-sheet strength

Debt / equity
2.16x
Current ratio
1.17x
Quick ratio
1.00x
Total debt
$9.70B
Total cash
$396.56M

Growth

How the business has been compounding

Revenue TTM
$1.00B
Revenue 5Y CAGR
-10.9%
EPS TTM
-0.05
EPS 5Y CAGR

Cash flow

How much cash the business throws off

Operating CF TTM
$216.12M
Free CF TTM
$230.77M
FCF margin
23.1%

Dividend

Shareholder payout

Yield
10.6%
Payout ratio
1,054.6%
Last ex-div date
2026-09-10